Edition:
United Kingdom

Ra Pharmaceuticals Inc (RARX.OQ)

RARX.OQ on NASDAQ Stock Exchange Global Market

7.51USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$7.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,029
52-wk High
$27.77
52-wk Low
$7.20

Latest Key Developments (Source: Significant Developments)

Ra Pharmaceuticals posts Q3 loss of $0.68 per share
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Ra Pharmaceuticals Inc :Ra pharmaceuticals reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.68.Q3 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S.As of September 30, 2017, Ra Pharma reported total cash and equivalents of $84.1 million​.Company expects that its cash and cash equivalents will be sufficient to fund operations through end of 2018​.  Full Article

Ra Pharmaceuticals files for mixed shelf offering of up to $250 million
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Ra Pharmaceuticals Inc :Ra Pharmaceuticals Inc files for mixed shelf offering of up to $250 million - SEC filing‍​.  Full Article

Lightstone Ventures LP reports 5.9 pct passive stake in Ra Pharmaceuticals Inc as on Dec 31, 2016
Tuesday, 14 Feb 2017 

Ra Pharmaceuticals Inc :Lightstone Ventures L.P. reports 5.9 percent passive stake in ra pharmaceuticals inc as on December 31, 2016 - SEC filing.  Full Article

BRIEF-Ra Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of RA101495 SC

* RA PHARMACEUTICALS ANNOUNCES POSITIVE INTERIM RESULTS FROM PHASE 2 STUDY OF RA101495 SC IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA